Who We Are

Lysine Biotech is a Chennai based start-up biotech company established in the year 2018. Lysine Biotech Private Limited at AIC-CCMB- Cohort-B of Standard Incubation.

We are currently involved in developing therapeutics against diabetics and acutely decompensated congestive heart failure with dyspnea at rest. Our aim is to provide affordable, safe and effective drugs/vaccine for diseases with global prevalence. We have i) Adeno-associated virus (AAV) vectors for gene delivery (SMN1,Parkin etc.,) for the treatment of a variety of human diseases ii)Development of anti-GeneX antibody-based CAR-T cells for treatment of cancer, iii) DARPin fourteen-in-One Pan croronavirus therapies designed for potential use against multiple microorganism COVID and iv) PROTAC has gained tremendous momentum for its promise to discover and develop new therapies in pipeline.

Lysine Biotech is committed to product development and manufacturing of drugs, biomarker and vaccines for several disease, Infectious diseases and biological molecules are produced from living organisms and range from DNA and protein through in-silico and wet lab technologies, which are useful for the medicinal and industrial applications.

Learn More About Us

Our Features

Our wild-type library of gene/mRNA and peptide/protein based vaccine development and technologies provide an opportunity to commercial license (IP) and manufacture products for customer needs.

Learn More About Technology